56 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
related to exposure to Hazardous Materials), including those related to Hazardous Materials or wastes, air emissions and discharges to waste or public
425
3clk u5y81mj41
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
dau 7cv24nz4ufcn3oe
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
w42vtphp4gxlw sy1x5o
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-2.1
rzf57f
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
x9fko7k az80fotypyt
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
EX-10.2
szugoj4
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
2uqizh
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
hbdttvm83xdgpf
26 Jan 11
Entry into a Material Definitive Agreement
12:00am